Tuesday, June 12, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, June 11, 2018 /PRNewswire/ -- Analysis of the Liquid Biopsy Market by Product, Biomarker, Sample, Cancer and End User, Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres

Read the full report: Report Details Liquid Biopsies ' our new study reveals trends, R&D progress, and predicted revenues Where is the liquid biopsy market heading? If you are involved
in this sector you must read this brand-new report. Visiongain's report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there. Discover How to Stay Ahead Our 156-page report provides 144 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing liquid biopsy market. See how to exploit the opportunities. Forecasts to 2028 and other analyses reveal the commercial prospects - In addition to revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares. - You find original analyses, with business outlooks and developments. - Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments. Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, you find revenue forecasts for 5 different segmentations of the market, including forecasts for 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end users: - Liquid biopsy Market Forecasts to 2028, By Product Type - Instruments - Kits & Reagents - Services - Liquid biopsy Market Forecasts to 2028, By Sample Type - Blood - Urine - Other - Liquid biopsy Technologies Market Forecasts to 2028, By Biomarker Type - CTC - ctDNA - Exosomes - Liquid biopsy Technologies Market Forecasts to 2028, By Application - Breast Cancer - Colorectal Cancer - Liver Cancer - Lung Cancer - Prostate Cancer - Other Cancers - Liquid biopsy Technologies Market Forecasts to 2028, By End User - Hospitals - Academic Institutes - Diagnostic Laboratories - Cancer Research Centres In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts 5 leading regional markets and 19 leading national markets: - North America - US - Canada - Europe - Germany - France - UK - Italy - Spain - Russia - Rest of Europe - APAC - Japan - China - India - South Korea - Singapore - Australia & New Zealand - Rest of APAC - Latin America - Brazil - Argentina - Rest of Latin America - MEA - GCC - South Africa - Rest of MEA There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2028. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market. Leading companies and the potential for market growth Overall world revenue for liquid biopsy will surpass $600bn in 2018, our work calculates. We predict strong revenue growth through to 2028. Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead. How the Liquid biopsy Technologies Market report helps you In summary, our 156-page report provides you with the following knowledge: - Revenue forecasts to 2028 for the world liquid biopsy market and 5 different segmentations, with 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end-user types ' discover the industry's prospects, finding the most lucrative places for investments and revenues - Revenue forecasts to 2028 for the leading 5 regional and 19 national markets ' North America (US, Canada), Latin America (Brazil, Argentina, Rest of Latin America), Europe(Germany, UK, France, Italy, Spain, Russia and Rest of Europe), APAC (Japan, China, India, South Korea, Singapore, Australia & New Zealand and Rest of APAC), LAMEA (GCC, South Africa and Rest of MEA) - Discussion of what stimulates and restrains companies and the market - Prospects for established firms and those seeking to enter the market Read the full report: About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:

SOURCE Reportlinker

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store